Adenoviruses as gene-delivery vehicles - PubMed (original) (raw)

Review

Adenoviruses as gene-delivery vehicles

J M Wilson. N Engl J Med. 1996.

No abstract available

PubMed Disclaimer

Similar articles

• Adenovirus-mediated gene transfer for cystic fibrosis: quantitative evaluation of repeated in vivo vector administration to the lung.
  Yei S, Mittereder N, Tang K, O'Sullivan C, Trapnell BC. Yei S, et al. Gene Ther. 1994 May;1(3):192-200. Gene Ther. 1994. PMID: 7584081
• Gene therapy.
  Wagner JA. Wagner JA. N Engl J Med. 1996 Feb 1;334(5):332-3. N Engl J Med. 1996. PMID: 8532041 No abstract available.
• [Gene therapy and adenovirus vectors].
  Zhang D, Lu H, Guo Q, Gao B, Zhu G. Zhang D, et al. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 1995 Dec;17(6):470-5. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 1995. PMID: 9208577 Review. Chinese. No abstract available.
• [Gene therapy of cystic fibrosis].
  Rochat T. Rochat T. Schweiz Med Wochenschr. 1999 Nov 20;129(46):1779-83. Schweiz Med Wochenschr. 1999. PMID: 10603652 Review. French.
• Adventures with adenovirus.
  [No authors listed] [No authors listed] Nat Genet. 1993 Jan;3(1):1-2. doi: 10.1038/ng0193-1. Nat Genet. 1993. PMID: 8490645 No abstract available.

Cited by

• A Replication-Defective Human Type 5 Adenovirus-Based Trivalent Vaccine Confers Complete Protection against Plague in Mice and Nonhuman Primates.
  Sha J, Kirtley ML, Klages C, Erova TE, Telepnev M, Ponnusamy D, Fitts EC, Baze WB, Sivasubramani SK, Lawrence WS, Patrikeev I, Peel JE, Andersson JA, Kozlova EV, Tiner BL, Peterson JW, McWilliams D, Patel S, Rothe E, Motin VL, Chopra AK. Sha J, et al. Clin Vaccine Immunol. 2016 Jul 5;23(7):586-600. doi: 10.1128/CVI.00150-16. Print 2016 Jul. Clin Vaccine Immunol. 2016. PMID: 27170642 Free PMC article.
• Water-soluble and low molecular weight chitosan-based plasmid DNA delivery.
  Lee M, Nah JW, Kwon Y, Koh JJ, Ko KS, Kim SW. Lee M, et al. Pharm Res. 2001 Apr;18(4):427-31. doi: 10.1023/a:1011037807261. Pharm Res. 2001. PMID: 11451027
• Airway epithelial CFTR mRNA expression in cystic fibrosis patients after repetitive administration of a recombinant adenovirus.
  Harvey BG, Leopold PL, Hackett NR, Grasso TM, Williams PM, Tucker AL, Kaner RJ, Ferris B, Gonda I, Sweeney TD, Ramalingam R, Kovesdi I, Shak S, Crystal RG. Harvey BG, et al. J Clin Invest. 1999 Nov;104(9):1245-55. doi: 10.1172/JCI7935. J Clin Invest. 1999. PMID: 10545523 Free PMC article. Clinical Trial.
• Akt/protein kinase B activation by adenovirus vectors contributes to NFkappaB-dependent CXCL10 expression.
  Liu Q, White LR, Clark SA, Heffner DJ, Winston BW, Tibbles LA, Muruve DA. Liu Q, et al. J Virol. 2005 Dec;79(23):14507-15. doi: 10.1128/JVI.79.23.14507-14515.2005. J Virol. 2005. PMID: 16282450 Free PMC article.
• Tumor-targeted delivery of biologically active TRAIL protein.
  Zhang HY, Man JH, Liang B, Zhou T, Wang CH, Li T, Li HY, Li WH, Jin BF, Zhang PJ, Zhao J, Pan X, He K, Gong WL, Zhang XM, Li AL. Zhang HY, et al. Cancer Gene Ther. 2010 May;17(5):334-43. doi: 10.1038/cgt.2009.76. Epub 2010 Jan 15. Cancer Gene Ther. 2010. PMID: 20075981 Free PMC article.

Publication types

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Ovid Technologies, Inc.

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information